South Africa is likely to withdraw approval of nevirapine in the prevention of mother-to-child transmission (MTCT) of HIV infections unless Boehringer Ingelheim produces new data to support the use of the drug in this indication,

 

作者: &NA;,  

 

期刊: PharmacoEconomics & Outcomes News Weekly  （ADIS Available online 2003）
卷期: Volume &NA;, issue 425  

页码: 7-7

 

ISSN:1173-5503

 

年代: 2003

 

出版商: ADIS

 

数据来源: ADIS

 

 

返 回